Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS3233 in Polycystic Ovary Syndrome
NCT01733459Phase 3Completed
- Sponsor
- Dexa Medica
- Start
- Mar 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS3233 in polycystic ovary syndrome (PCOS), sponsored by Dexa Medica. Started Mar 2013; status: completed.
02
Drugs
DLBS3233
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT01733459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733459.